The effect of pulmonary TB on the epidermal growth factor receptor (EGFR) in patients with lung adenocarcinoma (LAC) was investigated in 2019, and a significantly higher mutation frequency was found than in patients without tuberculosis (Hwang et al., 2019). The gene discussed is EGFR; the disease is pulmonary tuberculosis.